Edit |   |
---|---|
Antigenic Specificity | CD28 + EGFR (bispecific) |
Clone | monoclonal |
Host Species | Human |
Reactive Species | human |
Isotype | n/a |
Format | bispecific |
Size | n/a |
Concentration | n/a |
Applications | FuncS; Promising therapeutic agent; |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Human Anti-CD28 x Anti-EGFR Bispecific Antibody (IgG-IgG). Anti-CD28 x Anti-EGFR Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD28 and anti-EGFR parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy. |
Immunogen | n/a |
Other Names | CD28; CD28 molecule; Cluster of Differentiation 28; Tp44; T-cell-specific surface glycoprotein CD28; CD28 antigen |
Gene, Accession # | UniProt: P10747 |
Catalog # | BSIG-H232 |
Price | please inquire |
Order / More Info | CD28 + EGFR (bispecific) Antibody from CREATIVE BIOLABS, INC. |
Product Specific References | n/a |